Gelatinase B modulates selective opening of the blood-brain barrier during inflammation.
about
Effect of a short-term in vitro exposure to the marine toxin domoic acid on viability, tumor necrosis factor-alpha, matrix metalloproteinase-9 and superoxide anion release by rat neonatal microgliaMethamphetamine effects on blood-brain barrier structure and functionDIDS prevents ischemic membrane degradation in cultured hippocampal neurons by inhibiting matrix metalloproteinase releaseCyclooxygenase-1 and -2 differentially modulate lipopolysaccharide-induced blood-brain barrier disruption through matrix metalloproteinase activityEffects of aging on blood brain barrier and matrix metalloproteases following controlled cortical impact in mice.Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.MMP-9 levels in elderly patients with cognitive dysfunction after carotid surgery.Matrix metalloproteinase biology applied to vitreoretinal disorders.Association of matrix metalloproteinases with MRI indices of brain ischemia and agingMatrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis.Borrelia spirochetes upregulate release and activation of matrix metalloproteinase gelatinase B (MMP-9) and collagenase 1 (MMP-1) in human cellsThe role of angiogenesis in the pathology of multiple sclerosis.Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor.Methamphetamine and HIV-1 gp120 effects on lipopolysaccharide stimulated matrix metalloproteinase-9 production by human monocyte-derived macrophages.MMP9 deficiency does not decrease blood-brain barrier disruption, but increases astrocyte MMP3 expression during viral encephalomyelitis.Activation of matrix metalloproteinases-9 after photothrombotic spinal cord injury model in rats.Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood-brain barrier opening in rodents: Differences in response based on strains and solvents.Granzyme B-inhibitor serpina3n induces neuroprotection in vitro and in vivo.A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosisDifferential expression of matrix metalloproteinases in the serum of patients with mucopolysaccharidoses.Early beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brainDiverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.Matrix metalloproteinase-9 deficiency leads to prolonged foreign body response in the brain associated with increased IL-1beta levels and leakage of the blood-brain barrier.Matrix metalloproteases: underutilized targets for drug deliveryRAR/RXR and PPAR/RXR Signaling in Spinal Cord Injury.Thrombospondin 2-null mice display an altered brain foreign body response to polyvinyl alcohol sponge implantsThe role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse.Glomerular matrix metalloproteinases and their regulators in the pathogenesis of lupus nephritis.Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock.Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events.The effect of hypothermia on the expression of TIMP-3 after traumatic brain injury in rats.Peripheral ammonia and blood brain barrier structure and function after methamphetamine.The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomasThe significance of matrix metalloproteinases in parasitic infections involving the central nervous system.Ethanol Extract of Bupleurum falcatum Improves Functional Recovery by Inhibiting Matrix Metalloproteinases-2 and -9 Activation and Inflammation after Spinal Cord InjuryMatrix Metalloproteinase 9 in Epilepsy: The Role of Neuroinflammation in Seizure DevelopmentChronic brain inflammation causes a reduction in GluN2A and GluN2B subunits of NMDA receptors and an increase in the phosphorylation of mitogen-activated protein kinases in the hippocampus.Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier.Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND.The Role of Neurogenic Inflammation in Blood-Brain Barrier Disruption and Development of Cerebral Oedema Following Acute Central Nervous System (CNS) Injury.
P2860
Q24806568-EE597CC8-5C26-4AA3-9B5E-DEB3469C3684Q26825795-D1CCA923-8402-4B94-9819-1A97D7A8D1EAQ27321544-EFFB7B7F-AE71-4DB2-BA33-982054A449BCQ33638396-0C5A8D7A-91B1-4E7C-9024-4C0066B32612Q33702239-7741F8A2-DEAE-4F44-8AB4-7D37FD07483EQ33728244-EE01874E-5F67-4D18-A45C-F9142658D499Q33744879-46863878-DF1B-45C8-AF2F-CB627B00313AQ33933063-8FDD1972-46C7-46C2-B064-F21275FE0AAFQ33936858-EE2834BB-4F28-427C-9DF2-39EEAED48152Q34003220-D297095E-1CDA-493C-AE82-A20D8CCE434CQ34005707-86EAEA4E-0EFD-4358-A520-EC804108BD3DQ34620249-D6DE4913-5164-4008-BF3D-04AEE386A596Q35007289-0C68C7B4-9D44-4727-9A5D-265261F22FB1Q35032450-207DD2FB-922C-4529-80B8-2CEDF3889D69Q35216111-DBE478BB-D7CE-4D60-B53A-FE088BAC59DAQ35627073-4C369E58-0262-4129-9A72-8ECF9A82E722Q35774581-5AE9D085-D7E3-4678-AD35-E0564B9E564BQ36023188-77DEC4E3-6C8F-4A59-8887-23222222C5C5Q36175816-B49AD5B5-5BD4-4EDF-9C7B-B7888C85AB8DQ36433328-3DD752C7-032A-407C-A41E-9691896046FCQ36580516-D298ED83-A4AF-4BD4-B5BD-A83BECC6CEBDQ36644315-FD18C412-66BD-494C-A154-F88BFDD1D30CQ36761698-8D2A0F86-2B3F-420D-A8BE-7FF2F474CCCBQ36761849-9771C7A7-0067-40A3-8813-9B1DDFC4D0F1Q37024759-8611E360-6033-4E56-B9DE-D7136A3B7E56Q37171093-6A49F7F8-A1A8-4B58-B2B5-19DF272A9B85Q37245998-FC5F704C-7F2E-42F6-8600-E3CCD6219D6DQ37353175-B3FBAAD0-9886-4AD5-A340-55D4C0DACB9FQ37444400-1BB92AEC-31CF-4A5E-91C9-0613FF7A74D4Q37471962-15E5A905-215A-4138-8639-293A71FE2FDCQ37580093-5CCB6CC3-115A-4AEF-8CFD-4F7567464485Q37605025-7B04DCBD-207B-4F61-B728-B557D1CF97D6Q38136195-77834675-1B85-4A97-98C0-66DA10EFE8FAQ38273202-70F1E09F-49B8-4E8A-BE51-E1981D098284Q39064527-34A89769-F9E6-4DCA-9803-D3ECF7D67316Q39095751-CA45897F-C91A-4C86-99EC-C849AC2EEBA0Q39630580-A4067AF1-A843-493D-B167-038979452974Q40015379-11500CD6-FA80-4458-8DC1-18382090C7EBQ40167696-7D624253-4DE9-4505-A588-05632C501D1BQ41574379-B0B2E88C-0763-4DA2-B197-D2B15D8176BD
P2860
Gelatinase B modulates selective opening of the blood-brain barrier during inflammation.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Gelatinase B modulates selective opening of the blood-brain barrier during inflammation.
@en
Gelatinase B modulates selective opening of the blood-brain barrier during inflammation.
@nl
type
label
Gelatinase B modulates selective opening of the blood-brain barrier during inflammation.
@en
Gelatinase B modulates selective opening of the blood-brain barrier during inflammation.
@nl
prefLabel
Gelatinase B modulates selective opening of the blood-brain barrier during inflammation.
@en
Gelatinase B modulates selective opening of the blood-brain barrier during inflammation.
@nl
P1476
Gelatinase B modulates selective opening of the blood-brain barrier during inflammation
@en
P2093
G A Rosenberg
S Mun-Bryce
P304
P356
10.1152/AJPREGU.1998.274.5.R1203
P407
P577
1998-05-01T00:00:00Z